Kolgene vs FORE Biotherapeutics

Kolgene vs FORE Biotherapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kolgene is on 15/100 and FORE Biotherapeutics on 56/100.

Kolgene logo
KolgenePlatform for managing genetic test send-out operations for medical professionals.
Try Kolgene
FORE Biotherapeutics logo
FORE BiotherapeuticsPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
Try FORE Biotherapeutics

Where each one leads

Kolgene

  • headcount growth: +17.2% against +8.2%

FORE Biotherapeutics

  • our overall score: 56/100 against 15/100
  • agent readiness: 37/100 against 21/100
  • domain rating: 33/100 against 2/100
  • headcount: 56 against 2
  • LinkedIn following: 4,584 against 317

At a glance

MeasureKolgeneFORE Biotherapeutics
What it isPlatform for managing genetic test send-out operations for medical professionals.Precision oncology company developing cancer therapies guided by proprietary functional genomics.
CategoryHealthcare, Genomics, HealthTech, MedTechHealthcare, Drug Development, Genomics, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20162011
HeadquartersTel Aviv, IsraelPhiladelphia, United States
StatusInactiveActive

Size, funding and growth

MeasureKolgeneFORE Biotherapeutics
Employees256
Headcount growthLast 12 months+17.2%+8.2%
Total fundingNot published$232M
Latest roundBootstrappedSeries D-2 Extension
ValuationNot published$75.0M
LinkedIn followers3174,584

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureKolgeneFORE Biotherapeutics
StartupHub scoreOur 0-100 rating15/10056/100
Traction5/10058/100
TeamNot published70/100
Search visibility22/10038/100
QualityNot published55/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (37/100)
Domain ratingLink authority, 0-1002/10033/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureKolgeneFORE Biotherapeutics
CMSNot detectedWordPress
FrameworksNot detectedJquery

Kolgene vs FORE Biotherapeutics: common questions

Which is better, Kolgene or FORE Biotherapeutics?

On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Kolgene and FORE Biotherapeutics compare on the numbers?

Kolgene leads on headcount growth (+17.2% against +8.2%). FORE Biotherapeutics leads on our overall score (56/100 against 15/100), agent readiness (37/100 against 21/100), domain rating (33/100 against 2/100), headcount (56 against 2), LinkedIn following (4,584 against 317).

Read the full Kolgene review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Kolgene alternatives we track.